W Robert Taylor

1Emory University School of Medicine.

Publications of W Robert Taylor

  • GROWTH AND REGRESSION OF VASCULATURE IN HEALTHY AND DIABETIC MICE AFTER HIND LIMB ISCHEMIA.

    Authors: Natalia Landázuri, Giji Joseph, Robert E Guldberg, W Robert Taylor

    American journal of physiology. Regulatory, integrative and comparative physiology. 05/2012;

    The formation of vascular networks during embryogenesis and early stages of development encompasses complex and tightly regulated growth of blood vessels, followed by maturation of some vessels, and
  • Ultrasound Imaging of Oxidative Stress In Vivo with Chemically-Generated Gas Microbubbles.

    Authors: John Kangchun Perng, Seungjun Lee, Kousik Kundu, Charles F Caskey, Sarah F Knight, Sarp Satir, Katherine W Ferrara, W Robert Taylor, F Levent Degertekin, Daniel Sorescu, Niren Murthy

    Annals of biomedical engineering. 05/2012;

    Ultrasound contrast agents (UCAs) have tremendous potential for in vivo molecular imaging because of their high sensitivity. However, the diagnostic potential of UCAs has been difficult to exploit
  • Reactive Oxygen Species Regulate Osteopontin Expression in a Murine Model of Postischemic Neovascularization.

    Authors: Alicia N Lyle, Giji Joseph, Aaron E Fan, Daiana Weiss, Natalia Landázuri, W Robert Taylor

    Arteriosclerosis, thrombosis, and vascular biology. 04/2012;

    OBJECTIVE: Previous findings from our laboratory demonstrated that neovascularization was impaired in osteopontin (OPN) knockout animals. However, the mechanisms responsible for the regulation of OPN
  • Folate Receptor-Targeted Antioxidant Therapy Ameliorates Renal Ischemia-Reperfusion Injury.

    Authors: Sarah F Knight, Kousik Kundu, Giji Joseph, Sergey Dikalov, Daiana Weiss, Niren Murthy, W Robert Taylor

    Journal of the American Society of Nephrology : JASN. 01/2012;

    Antioxidant therapy can protect against ischemic injury, but the inability to selectively target the kidney would require extremely high doses to achieve effective local concentrations of drug. Here,
  • The changing face and abbreviated lives of bone marrow cells in the heart.

    Authors: Scott T Robinson, Natalia Landázuri, W Robert Taylor

    Arteriosclerosis, thrombosis, and vascular biology. 01/2012; 32(1):1-2.

  • Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis.

    Authors: Omar Saeed, Fumiyuki Otsuka, Rohini Polavarapu, Vinit Karmali, Daiana Weiss, Talina Davis, Brad Rostad, Kimberly Pachura, Lila Adams, John Elliott, W Robert Taylor, Jagat Narula, Frank Kolodgie, Renu Virmani, Charles C Hong, Aloke V Finn

    Arteriosclerosis, thrombosis, and vascular biology. 11/2011; 32(2):299-307.

    We recently reported that lowering of macrophage free intracellular iron increases expression of cholesterol efflux transporters ABCA1 and ABCG1 by reducing generation of reactive oxygen species. In
  • Redox signaling in an in vivo murine model of low magnitude oscillatory wall shear stress.

    Authors: Nick J Willett, Kousik Kundu, Sarah F Knight, Sergey Dikalov, Niren Murthy, W Robert Taylor

    Antioxidants & redox signaling. 09/2011; 15(5):1369-78.

    Wall Shear Stress (WSS) has been identified as an important factor in the pathogenesis of atherosclerosis. We utilized a novel murine aortic coarctation model to acutely create a region of low
  • A clinical commentary on the article "N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing" : N-acetylglucosamine conjugated nanoparticles: translational opportunities and barriers.

    Authors: Rebecca D Levit, W Robert Taylor

    Journal of cardiovascular translational research. 08/2011; 4(5):644-5.

    Targeting drugs and nanoparticles to cardiomyocytes has been an elusive challenge. Cardiomyocytes are inherently non-phagocytic and their environment is subjected to contractile forces which tend to
  • Overexpression of catalase in myeloid cells causes impaired postischemic neovascularization.

    Authors: Roberto Hodara, Daiana Weiss, Giji Joseph, Juan C Velasquez-Castano, Natalia Landázuri, Ji Woong Han, Young-sup Yoon, W Robert Taylor

    Arteriosclerosis, thrombosis, and vascular biology. 07/2011; 31(10):2203-9.

    Myeloid lineage cells (MLCs) such as macrophages are known to play a key role in postischemic neovascularization. However, the role of MLC-derived reactive oxygen species in this process and their
  • Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation.

    Authors: Kathryn Maiellaro-Rafferty, Daiana Weiss, Giji Joseph, William Wan, Rudolph L Gleason, W Robert Taylor

    American journal of physiology. Heart and circulatory physiology. 05/2011; 301(2):H355-62.

    The causality of the associations between cellular and mechanical mechanisms of abdominal aortic aneurysm (AAA) formation has not been completely defined. Because reactive oxygen species are
  • Effect of poly(ethylene glycol) diacrylate concentration on network properties and in vivo response of poly(β-amino ester) networks.

    Authors: David L Safranski, Daiana Weiss, J Brian Clark, Birgitta S Caspersen, W Robert Taylor, Ken Gall

    Journal of biomedical materials research. Part A. 02/2011; 96(2):320-9.

    Poly(β-amino ester) networks have shown promise as tissue scaffolds. The objective of this work was to examine the effect of changing poly(ethylene glycol) diacrylate concentration on poly(β-amino
  • Preferential activation of SMAD1/5/8 on the fibrosa endothelium in calcified human aortic valves--association with low BMP antagonists and SMAD6.

    Authors: Randall F Ankeny, Vinod H Thourani, Daiana Weiss, J David Vega, W Robert Taylor, Robert M Nerem, Hanjoong Jo

    PloS one. 01/2011; 6(6):e20969.

    Aortic valve (AV) calcification preferentially occurs on the fibrosa side while the ventricularis side remains relatively unaffected. Here, we tested the hypothesis that side-dependent activation of
  • Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.

    Authors: Antony Vinh, Wei Chen, Yelena Blinder, Daiana Weiss, W Robert Taylor, Jörg J Goronzy, Cornelia M Weyand, David G Harrison, Tomasz J Guzik

    Circulation. 12/2010; 122(24):2529-37.

    The pathogenesis of hypertension remains poorly understood, and treatment is often unsuccessful. Recent evidence suggests that the adaptive immune response plays an important role in this disease.
  • An in vivo murine model of low-magnitude oscillatory wall shear stress to address the molecular mechanisms of mechanotransduction--brief report.

    Authors: Nick J Willett, Robert C Long, Kathryn Maiellaro-Rafferty, Roy L Sutliff, Richard Shafer, John N Oshinski, Don P Giddens, Robert E Guldberg, W Robert Taylor

    Arteriosclerosis, thrombosis, and vascular biology. 11/2010; 30(11):2099-102.

    Current understanding of shear-sensitive signaling pathways has primarily been studied in vitro largely because of a lack of adequate in vivo models. Our objective was to develop a simple and
  • Temporal effects of catalase overexpression on healing after myocardial infarction.

    Authors: Karl D Pendergrass, Susan T Varghese, Kathryn Maiellaro-Rafferty, Milton E Brown, W Robert Taylor, Michael E Davis

    Circulation. Heart failure. 10/2010; 4(1):98-106.

    Reactive oxygen species, such as hydrogen peroxide (H(2)O(2)), contribute to progression of dysfunction after myocardial infarction (MI). However, chronic overexpression studies do not agree with
  • Shear stress and plaque development.

    Authors: Saurabh S Dhawan, Ravi P Avati Nanjundappa, Jonathan R Branch, W Robert Taylor, Arshed A Quyyumi, Hanjoong Jo, Michael C McDaniel, Jin Suo, Don Giddens, Habib Samady

    Expert review of cardiovascular therapy. 04/2010; 8(4):545-56.

    Although traditional cardiovascular risk factors 'prime the soil' for atherogenesis systemically, atherosclerosis primarily occurs in a site-specific manner with a predilection towards the inner wall
  • Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth.

    Authors: Justin S Golub, Young-tae Kim, Craig L Duvall, Ravi V Bellamkonda, Divya Gupta, Angela S Lin, Daiana Weiss, W Robert Taylor, Robert E Guldberg

    American journal of physiology. Heart and circulatory physiology. 03/2010; 298(6):H1959-65.

    Technologies to increase tissue vascularity are critically important to the fields of tissue engineering and cardiovascular medicine. Currently, limited technologies exist to encourage angiogenesis
  • Bioartificial matrices for therapeutic vascularization.

    Authors: Edward A Phelps, Natalia Landázuri, Peter M Thulé, W Robert Taylor, Andrés J García

    Proceedings of the National Academy of Sciences of the United States of America. 02/2010; 107(8):3323-8.

    Therapeutic vascularization remains a significant challenge in regenerative medicine applications. Whether the goal is to induce vascular growth in ischemic tissue or scale up tissue-engineered
  • Vascular wall ACE is not required for atherogenesis in ApoE(-/-) mice.

    Authors: Daiana Weiss, Kenneth E Bernstein, Sebastian Fuchs, Jonathan Adams, Andreas Synetos, W Robert Taylor

    Atherosclerosis. 10/2009;

    BACKGROUND: It has been proposed that elements of the renin angiotensin system expressed in the arterial wall are critical for the development of atherosclerosis. Angiotensin converting enzyme (ACE)

Are you W Robert Taylor?

Claim your profile

Keywords of W Robert Taylor

cell types
 
coronary arteries
 
endothelial cells
 
human coronary arteries
 
hydrogen peroxide
 
oxygen species
 
progenitor cells
 
protein expression
 
reactive oxygen species
 
shear stress
 
392.55
Impact Points
60
Publications

Institutions

  • 2004–2012
    • Georgia Institute of Technology
      • Biomedical Engineering
      Atlanta, GA, USA
  • 2002–2012
    • Emory University School of Medicine
      • • Biomedical Engineering
      • • Medicine
      Atlanta, GA, USA
  • 2002–2008
    • Emory University
      • • Department of Cardiology
      • • Department of Medicine
      Atlanta, GA, USA